Barry Clinch

666 total citations
21 papers, 427 citations indexed

About

Barry Clinch is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Barry Clinch has authored 21 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Barry Clinch's work include Influenza Virus Research Studies (19 papers), Respiratory viral infections research (12 papers) and Viral gastroenteritis research and epidemiology (4 papers). Barry Clinch is often cited by papers focused on Influenza Virus Research Studies (19 papers), Respiratory viral infections research (12 papers) and Viral gastroenteritis research and epidemiology (4 papers). Barry Clinch collaborates with scholars based in United Kingdom, Switzerland and United States. Barry Clinch's co-authors include Pedro A. Piedra, Nelson Lee, Neil Collinson, Steffen Wildum, Aeron C. Hurt, Hassan Zaraket, Ian Barr, Edward C. Holmes, Zuzana Dobbie and John Oxford and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Barry Clinch

21 papers receiving 421 citations

Peers

Countries citing papers authored by Barry Clinch

Since Specialization

Citations

This map shows the geographic impact of Barry Clinch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Clinch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Clinch more than expected).

Fields of papers citing papers by Barry Clinch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Clinch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Clinch. The network helps show where Barry Clinch may publish in the future.

Co-authorship network of co-authors of Barry Clinch

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Clinch. A scholar is included among the top collaborators of Barry Clinch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Clinch. Barry Clinch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Machine Learning to Detect Influenza Using Wearable Sensor Data and Patient-Reported Symptoms: Cohort Study 2024 ·Journal of Medical Internet Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Barry Clinch, Marco Prunotto, (unknown), (unknown), (unknown)	1
2	Novel modelling approaches to predict the role of antivirals in reducing influenza transmission 2023 ·PLoS Computational Biology ·Jason Asher, Annabelle Lemenuel‐Diot, (unknown), David P. Durham, Luis Mier-y-Terán-Romero, (unknown), (unknown), (unknown), (unknown), Barry Clinch, (unknown)	7
3	A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study) 2023 ·Microbiology Spectrum ·Marta Boffito, Eamon Dolan, (unknown), William C. Holmes, Steffen Wildum, (unknown), Keith Pietropaolo, Xiao‐Jian Zhou, Barry Clinch, Neil Collinson, (unknown)	5
4	Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial 2022 ·The Lancet Infectious Diseases ·Deepali Kumar, Michael G. Ison, Jean‐Paul Mira, Tobias Welte, Jick Hwan Ha, David S.C. Hui, Nanshan Zhong, Takefumi Saito, (unknown), Neil Collinson, Sarah Williams, Steffen Wildum, Andrew M. Ackrill, Barry Clinch, Nelson Lee	59
5	Predictors of Seeking Care for Influenza-Like Illness in a Novel Digital Study 2022 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), Allison Shapiro, Ernesto Ramirez, (unknown), Luca Foschini, Faye Drawnel, Barry Clinch, Marco Prunotto, (unknown)	6
6	Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model 2021 ·PLoS Pathogens ·Leo Lee, Jie Zhou, (unknown), Rebecca Frise, (unknown), Keiko Baba, Shahjahan Miah, Takao Shishido, Mónica Galiano, Takashi Hashimoto, Shinya Omoto, Takeki Uehara, Edin Mifsud, Neil Collinson, (unknown), Barry Clinch, Steffen Wildum, William Barclay, Aeron C. Hurt	29
7	Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS) 2021 ·Antiviral Research ·(unknown), Martin Schutten, (unknown), Barry Clinch, Anne van der Linden, Ron A. M. Fouchier, Pieter L. A. Fraaij	3
8	Understanding the Impact of Resistance to Influenza Antivirals 2021 ·Clinical Microbiology Reviews ·Edward C. Holmes, Aeron C. Hurt, Zuzana Dobbie, Barry Clinch, John Oxford, Pedro A. Piedra	51
9	Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children 2020 ·The Pediatric Infectious Disease Journal ·Jeffrey P. Baker, S. Block, Balpreet Matharu, (unknown), Steffen Wildum, Sophie Dimonaco, Neil Collinson, Barry Clinch, Pedro A. Piedra	62
10	Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission 2020 ·PLoS Pathogens ·Leo Lee, Jie Zhou, Rebecca Frise, Daniel H. Goldhill, (unknown), Edin Mifsud, (unknown), Takahiro Noda, (unknown), Kenji Sato, (unknown), Takao Shishido, Takeki Uehara, Steffen Wildum, (unknown), Neil Collinson, (unknown), Barry Clinch, Aeron C. Hurt, William Barclay	31
11	Burden of influenza B virus infection and considerations for clinical management 2020 ·Antiviral Research ·Hassan Zaraket, Aeron C. Hurt, Barry Clinch, Ian Barr, Nelson Lee	52
12	Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants 2020 ·Clinical Pharmacology & Therapeutics ·Leonid Gibiansky, Patanjali Ravva, Neil Parrott, Rajinder Bhardwaj, (unknown), (unknown), Barry Clinch, (unknown)	4
13	Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS) 2019 ·Clinical Infectious Diseases ·(unknown), (unknown), A. Kenwright, Martin Schutten, Charles A. Boucher, Arnold S. Monto, Barry Clinch, Deepali Kumar, Richard J. Whitley, Jonathan S. Nguyen‐Van‐Tam, Albert D. M. E. Osterhaus, Ron A. M. Fouchier, Pieter L.A. Fraaij	21
14	Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients 2019 ·Infectious Diseases and Therapy ·Essack Mitha, Gergely Kriván, Frédérique Jacobs, Arnon Nagler, (unknown), Analía Mykietiuk, (unknown), Sophie Le Pogam, Barry Clinch, (unknown)	18
15	Oseltamivir in pregnancy and birth outcomes 2018 ·BMC Infectious Diseases ·Véra Ehrenstein, Nickolaj Risbo Kristensen, Brigitta U. Monz, Barry Clinch, A. Kenwright, Henrik Toft Sørensen	19
16	Roche perspectives on Tamiflu 2015 ·Clinical Microbiology and Infection ·Barry Clinch, James Smith	3
17	Investigating Clinically Adequate Concentrations of Oseltamivir Carboxylate in End-Stage Renal Disease Patients Undergoing Hemodialysis Using a Population Pharmacokinetic Approach 2015 ·Antimicrobial Agents and Chemotherapy ·Mohamed Kamal, (unknown), Richard A. Robson, Vishak Subramoney, Barry Clinch, Craig R. Rayner, Leonid Gibiansky	4
18	The Posology of Oseltamivir in Infants With Influenza Infection Using a Population Pharmacokinetic Approach 2014 ·Clinical Pharmacology & Therapeutics ·Mohamed Kamal, Edward P. Acosta, David W. Kimberlin, Leonid Gibiansky, Penelope Jester, Vis Niranjan, Barbara Rath, Barry Clinch, Pablo J. Sánchez, Krow Ampofo, Richard J. Whitley, Craig R. Rayner	19
19	Effect of bone-conduction harmonic distortions on hearing thresholds 2014 ·The Journal of the Acoustical Society of America ·(unknown), Harvey Dillon, Barry Clinch, (unknown)	22
20	Safety, Virology and Pharmacokinetics of Oseltamivir in Infants with Laboratory-Confirmed Influenza: A Phase I/II, Prospective, Open-Label, Multicentre Clinical Trial 2014 ·Antiviral Therapy ·Barbara Rath, Jerzy Brzostek, Sara Guillén, (unknown), Colombe Chappey, Craig R. Rayner, Barry Clinch	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact